{"slideshow_credits": null, "snippet": "Gary Tanner, the former Valeant executive, entered into a secret relationship with Philidor\u2019s chief executive, Andrew Davenport, federal authorities said....", "abstract": "Federal prosecutors charge Philidor Rx Services chief exec Andrew Davenport and Valeant Pharmaceuticals International exec Gary Tanner with multiple counts of fraud and conspiracy; allege two made secret pact to enrich themselves through promotion of Philidor through Valeant via bribes and kickbacks.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Katie", "role": "reported", "lastname": "THOMAS", "rank": 1, "organization": ""}, {"firstname": "Matthew", "role": "reported", "lastname": "GOLDSTEIN", "rank": 2, "organization": ""}], "original": "By KATIE THOMAS and MATTHEW GOLDSTEIN"}, "web_url": "http://www.nytimes.com/2016/11/18/business/valeant-philidor-fraud-kickback-scheme.html", "lead_paragraph": "Gary Tanner, the former Valeant executive, entered into a secret relationship with Philidor\u2019s chief executive, Andrew Davenport, federal authorities said.", "headline": {"main": "Former Drug Industry Executives Charged in Kickback Scheme", "print_headline": "Charges in Drug Industry Kickbacks Case"}, "_id": "582dce9d7c459f6a5fcce8cc", "word_count": "1310", "multimedia": [{"height": 126, "url": "images/2016/11/18/business/18VALEANTsub/18VALEANTsub-thumbWide-v2.jpg", "legacy": {"wideheight": "126", "wide": "images/2016/11/18/business/18VALEANTsub/18VALEANTsub-thumbWide-v2.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 431, "url": "images/2016/11/18/business/18VALEANTsub/18VALEANTsub-articleLarge-v2.jpg", "legacy": {"xlarge": "images/2016/11/18/business/18VALEANTsub/18VALEANTsub-articleLarge-v2.jpg", "xlargewidth": "600", "xlargeheight": "431"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2016/11/18/business/18VALEANTsub/18VALEANTsub-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2016/11/18/business/18VALEANTsub/18VALEANTsub-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2016-11-17T15:36:54Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "is_major": "Y", "rank": "1"}, {"name": "organizations", "value": "Philidor Rx Services LLC", "is_major": "Y", "rank": "2"}, {"name": "subject", "value": "Bribery and Kickbacks", "is_major": "Y", "rank": "3"}, {"name": "persons", "value": "Tanner, Gary", "is_major": "Y", "rank": "4"}, {"name": "persons", "value": "Davenport, Andrew", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": null, "type_of_material": "News"}